NCT02780362View on ClinicalTrials.gov

Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Healthy

Interventions

DRUG

Prodactariv

1 tablet contains 60 mg Daclatasvir

DRUG

Clatazev

1 tablet contains 60 mg Daclatasvir

Trial Locations (1)

11757

Genuine Research Center GRC, Cairo

All Listed Sponsors

collaborator

International Drug Agency for Pharmaceutical Industry

OTHER

lead

Genuine Research Center, Egypt

INDUSTRY

NCT02780362 - Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK) | Biotech Hunter | Biotech Hunter